Back to Report Store Home

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

  • Published: Jul-2011
  • Report Code: GBICH0051MR
  • Report Format: pdf

Description

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 GBI Report Coverage 8

3 Asia-Pacific API Market 9

3.1 Asia-Pacific API Industry Structure 9

3.2 Asia-Pacific API Distribution Structure 10

3.3 Asia-Pacific API Industry Challenges 10

3.3.1 Growing Capacity May Prove out to be Surplus and become a Challenge to the Producers 10

3.3.2 Price Fluctuations Affect the Revenue Growth of the Asia-Pacific API market 10

3.3.3 Rising Raw Material Costs in India and China Threaten the Profit Margins of API Producers 10

3.4 Asia-Pacific API Market Overview 11

3.5 Asia-Pacific API Market Trends 12

3.5.1 API Manufacturing is Shifting from Western Countries to China and India 12

3.5.2 Indian Companies are Exporting to Japanese Market to Beat the Price Erosion in the US 12

3.5.3 Japanese Generic Market is Attracting Tie-Ups by Global Companies 12

3.5.4 The Focus on Biotech API Drugs in Asia-Pacific is Increasing 12

3.5.5 Some Companies in India are Making a Move Towards HPAPIs 12

3.5.6 Peptide APIs are Offering Growth Opportunities for the Region’s Market 13

3.5.7 Indian Producers are Becoming Keen on Expansion Through Acquisitions 13

3.6 Asia-Pacific API Market Revenue Analysis and Forecasts to 2015 13

3.7 Asia-Pacific API Market Revenue Share Analysis by Product Type and Forecasts to 2016 15

3.7.1 Asia-Pacific API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 16

3.7.2 Asia-Pacific API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 19

3.8 Asia-Pacific API Market Revenue Share Analysis by Country and Forecasts to 2016 22

3.9 Asia-Pacific API Market Competitive Landscape 23

3.10 Force Field Analysis on Transition Toward Biotech API 24

3.10.1 Push Forces 25

3.10.2 Pull Forces 26

3.10.3 Conclusion 26

4 Japan API Market 27

4.1 Japan API Market Overview 27

4.2 Japan API Market Drivers 28

4.2.1 Increased Focus on Generic Sector Drugs will Help the Growth of the Overall API Market in Japan 28

4.2.2 Government Support for Generic Drugs Boosts the Country’s API Market 28

4.2.3 Growth in the Ageing Population Drives the Growth of the API Market in Japan 28

4.3 Japan API Market Restraints 28

4.3.1 Mature Pharmaceutical Market Allows Less Scope for Growth to the API Market in the Country 28

4.3.2 Lesser Focus on Innovative Drugs to Reduce Healthcare Expenses May Hamper the Growth of the Japanese API market 28

4.4 Japan API Market Revenue Analysis and Forecasts to 2015 29

4.5 Japan API Market Revenue Share Analysis by Product Type and Forecasts to 2015 31

4.5.1 Japan API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 31

4.5.2 Japan API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 34

4.6 Japan API Market Revenue Share Analysis by Therapeutic Category 37

4.7 Japan API Market SWOT Analysis 39

4.7.1 Strengths 39

4.7.2 Weaknesses 40

4.7.3 Opportunities 40

4.7.4 Threats 41

5 China API Market 42

5.1 China API Market Overview 42

5.2 China API Market Drivers 43

5.2.1 Rapidly Growing Economy Supports the Growth of the API Market 43

5.2.2 Growth in the Generics Drug Sector Spurs the Growth in Demand for APIs 43

5.2.3 Government’s Plan to Develop Multi-level Insurance System Set to Boost the Growth of the API Market in China 43

5.2.4 Development in Biotech Drugs Improves the Growth of Biotech APIs 43

5.3 China API Market Restraints 43

5.3.1 Price Erosion Reduces the Revenue Growth of the API Market in China 43

5.3.2 The Global Economic Downturn in the Last Few Years has Impacted the Demand in the Chinese API Market 43

5.4 China API Market Revenue Analysis and Forecasts to 2015 44

5.5 China API Market Revenue Share Analysis by Product Type and Forecasts to 2015 46

5.5.1 China API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 46

5.5.2 China API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 49

5.6 China API Market Revenue Share Analysis by Therapeutic Category 52

5.7 China API Import and Export Analysis 54

5.8 China API Market SWOT Analysis 58

5.8.1 Strengths 58

5.8.2 Weaknesses 59

5.8.3 Opportunities 59

5.8.4 Threats 59

6 India API Market 60

6.1 India API Market Overview 60

6.2 India API Market Drivers 60

6.2.1 Population Growth and Change in Demographics Set to Boost the Growth of API Market 60

6.2.2 Increasing Demand in Rural Areas and Tier II Cities Boost the Growth of API Market in India 60

6.2.3 Increasing Spending Capacity on Healthcare Facilities 61

6.3 India API Market Restraints 61

6.3.1 Price Erosion Leads to Reduced Growth in the Overall API Market 61

6.3.2 Economic Recession Leads to Reduced Consumption of API 61

6.4 India API Market Revenue Analysis and Forecasts to 2015 61

6.5 India API Market Revenue Share Analysis by Product Type and Forecasts to 2015 63

6.5.1 India API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 63

6.5.2 India API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 66

6.6 India API Market Revenue Share Analysis by Therapeutic Category 69

6.7 India API Market SWOT Analysis 71

6.7.1 Strengths 71

6.7.2 Weaknesses 72

6.7.3 Opportunities 72

6.7.4 Threats 72

7 South Korea API Market 73

7.1 South Korea API Market Overview 73

7.2 South Korea API Market Drivers 73

7.2.1 Continued Growth in Generics Will Help the API Market Growth in South Korea 73

7.2.2 Increasing Focus on the Innovator Sector Will Drive the API Market 73

7.2.3 Support from the Government Will Help Growth in Innovator and Biotech Sector 73

7.3 South Korea API Market Restraints 73

7.3.1 Delay in Drug Development Process 73

7.4 South Korea API Market Revenue Analysis and Forecasts to 2015 74

7.5 South Korea API Market Revenue Share Analysis by Product Type and Forecasts to 2015 76

7.5.1 South Korea API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015 76

7.5.2 South Korea API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015 79

7.6 South Korea API Market Revenue Share Analysis by Therapeutic Category 82

7.7 South Korea API Market SWOT Analysis 84

7.7.1 Strengths 84

7.7.2 Weaknesses 84

7.7.3 Opportunities 85

7.7.4 Threats 85

8 Appendix 86

8.1 Abbreviations 86

8.2 Market Definitions 86

8.3 Methodology 86

8.3.1 Coverage 86

8.3.2 Secondary Research 87

8.3.3 Primary Research 87

8.3.4 Expert Panel Validation 87

8.4 Contact Us 87

8.5 Disclaimer 88

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$1000
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$2000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$3000
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards